Beyond the Heart: Managing Cytopenias and Other Side Effects of BTK Inhibitors
Presenter: Apryl Moss, DNP, APRN, FNP-C | Advanced Cancer Treatment Centers
BTK inhibitors can be transformative for patients—but they also come with side effects that aren’t always straightforward to spot or manage. For many teams, the real challenge isn’t starting therapy… it’s navigating the fatigue, cytopenias, and day-to-day toxicities that show up weeks or months later.
In this session, Apryl Moss, DNP, APRN, FNP-C, breaks down what clinicians need to pay attention to beyond the heart. She’ll connect the history of BTK inhibitors to the side effects we see now, and offer practical, patient-centered approaches for identifying and managing these issues early.
Walk away with:
- A clearer understanding of how BTK inhibitors developed and why their mechanism matters
- A simple way to think about class-wide toxicities and what they mean for your patients
- How to spot and manage cytopenias before they impact treatment
- Guidance for addressing other meaningful AEs—from headaches and fatigue to arthralgias and secondary malignancies
For additional information or login assistance, reach out to NCODA’s Jonathan Rivera.
Additional Upcoming Webinars
June 25, 2026 | 2:00 PM
Upcoming Webinar
Techs Talk The Importance of Oral Health for Oncology Patients
July 8, 2026 | 3:00 PM